|
 |
|
| |
Message From The Company |
|
|
|
A Message from Phase Forward
Phase Forward is a provider of integrated enterprise-level
software products, services, and hosted solutions for use in the
clinical trial component of its customers' global research and
development initiatives. Phase Forward's customers include
pharmaceutical, biotechnology, and medical device companies, as well
as academic institutions, clinical research organizations, and other
entities engaged in clinical trials. By automating essential elements
of the clinical trial process, the Company believes its products allow
its customers to accelerate the market introduction of new medical
therapies and corresponding revenue, reduce overall research and
development expenditures, enhance existing data quality control
efforts, and reduce clinical and economic risk. Phase Forward believes
its enterprise software and hosted solutions are the most widely
adopted commercial data capture, data management, and adverse event
reporting solutions in the clinical trial marketplace, having been
utilized in over 10,000 clinical trials involving more than 1,000,000
clinical trial study participants and 300 therapeutic compounds and
medical devices. Phase Forward's customer base of over 220 customers
is comprised of the leading pharmaceutical, biotechnology, medical
device, and clinical research organizations, including AstraZeneca
Pharmaceuticals LP, Aventis S.A., Biogen Idec Inc., Eli Lilly and
Company, GlaxoSmithKline plc, Guidant Corporation, Institut de
Recherches Internationales Servier, Pfizer Canada, The Procter &
Gamble Company, Sanofi-Synthelabo, Schering-Plough Research Institute,
and Serono S.A.. Phase Forward is headquartered in Waltham,
Massachusetts with offices in the United Kingdom, Australia, France,
and Japan. Additional information about Phase Forward is available at
www.phaseforward.com. |
|
| Our Most Recent Webcast |
 |
| SYMBOL |
EVENT TITLE |
LISTEN |
DATE |
TIME (ET) |
| PFWD |
Q4 2009 Phase Forward Incorporated Earnings Conference Call |
 |
4-Feb-10 |
5:00 PM |
|
| Our Most Recent Annual Report |
|
|
